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C-type viruses have long been implicated in the etiology of spontaneous lymphomas 
or leukemias of  mice. This inference was grounded, in part, in the early demonstrations 
by Gross  (1)  and  others  (2-4)  of the existence of filterable leukemogenic agents in 
AKR mice or transplanted  murine tumors, and, in  part, in the realization that  C- 
type viruses are abundant in high leukemia-incidence mice such as AKR. It has since 
become  apparent  that  a  number  of distinct  C-type  or  murine  leukemia  viruses 
(MuLV) 1 are endogenous in mice, that they are inherited as normal components of 
the mouse genome, and that many of these viruses are not pathogenic (5-7). 
MuLV are generally classified on the basis of their host range as ecotropic (capable 
of infecting mouse cells, but generally not cells of other species), xenotropic (capable 
of infecting only  heterologous  species  cells),  or  amphotropic  (wild  mouse  viruses 
infectious for both  mouse and  heterologous species cells).  Serological, interference, 
and biochemical studies of these viruses have shown significant differences between 
various isolates but have generally supported the host-range classification. The variety 
of MuLV  has  been  further compounded  by  the  recent  discovery of new  types  of 
viruses that apparently are genetic recombinants between endogenous ecotropic and 
xenotropic viruses (8, 9). These viruses, designated mink cell focus-inducing (MCF) 
viruses because of their ability to induce focal growth or morphological changes in a 
mink lung tissue culture cell line, possess properties of both ecotropic and xenotropic 
viruses.  They are  dual-tropic  in  host  range  (capable of infecting both  mouse and 
certain heterologous species cells), they are interfered with by both kinds of viruses, 
they induce both ecotropic and xenotropic MuLV-specific antigens on cells (10), and 
they possess both ecotropic and xenotropic MuLV gp70 (11)  and RNA components 
(12).  Collectively, the evidence strongly points to a  recombinational origin for MCF 
MuLV and important questions have thus been raised concerning the mechanisms of 
such genetic rearrangements and the biological consequences thereof. 
Although the AKR-247 and AKR-13 MCF strains have already been shown to be 
leukemogenic in AKR (13), most MCF viruses, as well as many of the other classes of 
viruses  isolated  from  mice,  have  not  been  adequately  characterized  as  to  their 
oncogenicity. Consequently it remains uncertain at this point which of the currently 
defined  types  of MuLV,  if any,  are  involved  in  the  development of spontaneous 
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murine lymphoma. The MCF viruses are suspect because (a)  they have been isolated 
only from late preleukemic or leukemic mice,  (b)  they are found only in the thymus 
of late  preleukemic  AKR  mice  (the  thymus being the  target  organ  in spontaneous 
AKR  lymphoma),  and  (c)  they are  associated  with  many of the widely used  leuke- 
mogenic laboratory MuLV strains (Friend, Moloney, Rauscher)  (8, 14) (M. W. Cloyd, 
J. W. Hartley, and W. P. Rowe. Unpublished  data.).  We report herein the results of 
leukemogenicity studies  of MCF  and  other  classes  of MuLV.  Acceleration  of lym- 
phoma in AKR mice (15) after inoculation of various cloned MuLV was the primary 
test model, but other strains of mice were also tested. 
Materials and Methods 
Viruses and Virus Assays.  MCF viruses were isolated  from mice by plating  mitomycin C- 
treated lymphoid cells as infectious centers onto mink lung (ATCC CCL-64) or SC-1  (16) cells 
as described previously (9). The viruses were adapted  to cell-free  passage in mink lung cell 
cultures and were carried through two cycles of limiting dilution purification. Virus pools used 
for inoculation were cell plus fluid harvests from chronically infected cultures collected within 
24 h after feeding; they were frozen, thawed, and clarified by centrifugation at  1,200 g for 20 
rain. The viruses used in this study and the methods of quantitation are described in Table I. 
All ecotropic, amphotropic, and MCF viruses  used are N-tropic, except  CB208, which is B- 
tropic. 
In some tests, xenotropic viruses were inoculated as phenotypically mixed virus populations 
that contained xenotropic virus genomes with ecotropic virus envelope specificity. Two prepa- 
rations  were  tested:  one,  designated  BALB-IU-I  (AKR L1),  was obtained  from  SC-1  cells 
chronically infected with BALB-IU-I xenotropic virus and superinfected with AKR ecotropic 
MuLV; the second, designated AKR 2B-X (AKR2B-Eco), was a phenotypic mixture between 
5-iododeoxyuridine  (IUdR)-induced  endogenous  ecotropic  and  xenotropic  viruses  from  an 
AKR embryo cell  line  and  was supplied  by M.  Lander of the  National  Cancer  Institute, 
Bethesda, Md. Fluid from these cell cultures contained both parental and phenotypically mixed 
particles as described elsewhere (18). Quantitation of xenotropic genomes with ecotropic virus- 
specified  host range was performed by titrating in SC-1 cells, UV-killing these cells 2-3 d later, 
and overlaying with mink S+L  - indicator cells (19); the titers obtained with the two pools were 
l03'° and  1041 focus-forming units (flu)/0.2 ml, respectively. 
Replication in vivo of inoculated MCF viruses was quantitated  by infectious-center assays. 
AKR mice were sacrificed 3-6 wk after inoculation; thymus and spleen cells were mitomycin- 
C  treated  and  plated onto mink lung cells  at  107, 106, and  105 cells/plate.  MCF virus was 
quantitated  by scoring for loci  of cytopathic alteration;  cultures  that  did  not  demonstrate 
characteristic cytopathic effect (CPE) were transferred and observed for development of MCF- 
type CPE. 
Mice and Leukemogenicity Assays.  AKR/J,  DBA/2J, and  C57BR/CdJ  mice were obtained 
from The Jackson Laboratory, Bar Harbor, Maine; C58/Lw mice were kindly supplied by Dr. 
Lloyd Law of the National  Institutes of Health,  Bethesda,  Md.;  mice of the C3H/Bi strain 
were obtained from Microbiological Associates,  Walkersville, Md.; and NFS/N, C57L/N, and 
BALB/cN mice were obtained from the National Institutes of Health Small Animal Colony. 
Sw.Akv-l, Sw.Akv-2, Sw.C58v-l, Sw.C58v-2, and Sw.Fgv-1 are NFS or NIH Swiss mice partially 
congenic for the respective ecotropic virus-inducing loci and are lines developed and maintained 
in our laboratory. 
Mice were inoculated as sucklings (2-5 d of age) or at 1 mo of age with -0.02 ml of undiluted 
virus suspension; this corresponded to 104'°-5"9  plaque-forming units for ecotropic viruses,  and 
10  zn47 CPE-inducing units for MCF viruses.  In most of the tests, the mice were injected in the 
region of the  thymus,  but  in  some cases  the  mice were  injected  intraperitoneally,  or both 
intrathymically and  intraperitoneally.  Mice were checked weekly for gross evidence of lym- 
phoma,  and  moribund  mice were sacrificed  for autopsy.  Only those with  grossly enlarged 
lymphoid  organs  were  regarded  as  leukemic;  histologic  examination  of selected  animals 
confirmed the presence of lymphoid neoplasms. In AKR mice, lymphoma development before TABLE  I 
Nomenclature,  Origin, and Titers of Virus Strains 
Virus* 
Class  Strain 
Source 
Mouse strain (age)  Tissue 
Titer:~ 
Log10 in- 
fectious 
units per 
0.2 ml 
Ecotropic  AKRL  1 
AKR-Th-2a 
Akv-l-Tl 
Akv-2-T1 
A kv- 1  - L 1 
Akv- I-L2 
F/ST-Th- 1 
BBR-1-N 
WN 1802N 
C58-Lla 
Xenotropic  BALB-IU- 1 
Amphotropic  4070A 
1504A 
Cas.L1-A 
MCF  AKR-247 
AKR-13 
AKR-L3 
AKR-L4 
AKR-L5 
AKR-  1659 
NS ×  AK-L1 
Akv- 1-C36 
Akv- 1-C93 
Akv-2-C34 
Akv-2-C35 
Akv-2-C78 
Akv-2-C26-2 
AKR 
AKR (2 mo) 
Sw.Akv-1 (1 mo) 
Sw.Akv-2 (5 wk) 
Sw.Akv-I (3 mo) 
Sw.Akv-I (2.5 too) 
F/St (1 too) 
B10.BR 
BALB/c (18 mo) 
C58/Lw (10 mo) 
BALB/c 
Wild mouse (Calif.) 
Wild mouse (Calif.) 
Wild mouse (Calif.) 
AKR/J (6 mo) 
AKR/J (3 mo) 
grafted with 6- 
mo-old AKR thy- 
mus 
AKR/J 
AKR/J (9 too) 
AKR/J (9 mo) 
AKR/J (6 mo) 
(NFS  X  AKR)F~  (1 
yr) 
Sw.Akv-I (13 mo) 
Sw.Akv-I (18 mo) 
Sw.Akv-2 (10 mo) 
Sw.Akv-2 (18 mo) 
Sw.Akv-2 (10 mo) 
Sw.Akv-2 (23 mo) 
Akv-2-C25  Sw.Akv-2 (I 7 mo) 
C58v-1-C48  Sw.C58v-I (14 mo) 
C58v-1-C77  Sw.C58v-I (17 mo) 
C58v-2-C45  Sw.C58v-2 (20 mo) 
Fgv-l-C647  Sw.Fgv-I (10 mo) 
Fg-L3  C3HFg/Lw (10 mo) 
C58-Llb  C58/Lw (10 mo) 
CB208  BALB/c 
Leukemic  spleen,  thymus, and  5.9 
lymph nodes 
Thymus  5.4 
Tail  6.6 
Tail  6.7 
Thymoma  6.5 
Thymoma  NT 
Thymus  5.1 
IUdR-treated embryo cells  6.3 
Spleen  6.9 
Thymoma  5.0 
IUdR-treated embryo cells  4.2 
Embryo  5.5 
Embryo  4.7 
Leukemic  mesenteric lymph  NT 
node 
Thymus  4.5-5.7 
Thymus  4.6-4.9 
Thymoma  4.6 
Thymoma  4.1 
Thymoma  3.5 
Thymus  5.6 
Leukemic  mesenteric lymph  4.0 
node 
Thymoma or leukemic  medias-  3.6-4.1 
tinal lymph node 
Splenic  mixed  hematopoietic  4.2 
neoplasm 
Splenic  mixed  hematopoietic  3.8-4.1 
neoplasm 
Lymph node with reticulum cell  4.9 
sarcoma 
Leukemic cervical lymph node  4.7 
Spleen and lymph nodes con-  4.8 
taining reticulum cell sar- 
coma 
Splenic reticulum cell sarcoma  4.4 
Splenic reticulum cell sarcoma  4.6 
Splenic reticulum cell sarcoma  4.5 
Splenic reticulum cell sarcoma  4.9 
Leukemic  lymph nodes  3.8-4.4 
Leukemic spleen  4.4 
Thymoma  4.0 
Pristane-induced  transplanted  4.0 
plasmacytoma. 
* Ecotropic viruses were grown in SC-1 or NFS embryo cells. Xenotropic, amphotropic, and MCF viruses 
were propagated in mink lung cells (CCL64). 
:~ Ecotropic viruses were quantitated in SC-~ cells by the UV-XC procedure (17). Xenotropic and wild 
mouse  amphotropic viruses were  titrated on mink S+L  -  cells (19). MCF viruses were quantitated by 
focus-formation  in mink lung cells (9). NT, not tested. 
544 M. W. CLOYD, J.  W.  HARTLEY, AND W.  P.  ROWE  545 
6 mo of age was considered an accelerated response (15). Other strains of mice were observed 
for 1-1.5 yr after inoculation. 
Results 
Ability  of  Various Classes of MuLV  to  Accelerate Development of Lymphoma in  AKR 
Mice.  MuLV isolates of different classes (MCF, ecotropic, xenotropic, and ampho- 
tropic) were tested in the AKR acceleration test. As summarized in Table II, all six 
cloned MCF  isolates from preleukemic and  leukemic thymuses of AKR mice were 
highly effective in accelerating development of AKR lymphoma; each induced disease 
in  100% of recipients, usually within  2-4 mo after inoculation. All presented with 
thymomas, usually accompanied by involvement of other lymphoid organs. 
In contrast, many MCF viruses, nearly all of which were from nonthymic neoplasms 
in strains other than AKR, were not lymphomagenic in AKR mice (Table II). These 
included one MCF  isolate each  from C3H/Fg  and  (NFS  ×  AKR)F1  mice, and  a 
number of isolates from Swiss mice partially congenic for Akv-1, Akv-2, Fgv-1, C58v-1, 
and  C58v-2 ecotropic virus-inducing loci. Also, the B-tropic CB208 MCF virus was 
negative, as might be expected from the restriction of B-tropic viruses in AKR mice. 
Only one MCF isolate of non-AKR origin, from a C58 thymoma (C58Llb), was able 
to accelerate AKR lymphoma. 
Two strains of AKR ecotropic virus  (AKRL1  and AKR-th-2a), eeotropic viruses 
from Akv-1  and Akv-2 congenie mice (Akv-l-T1, Akv-2-T1, Akv-l-L1,  and Akv-l-L2), 
an N-tropic virus from BALB/c (WN1802N), and ecotropic isolates from C58, F/St, 
and B10.BR did not accelerate AKR lymphoma. A xenotropic isolate (BALB-IU-1) 
was also not effective in lymphoma acceleration, but this was expected because this 
class  of virus  does  not  infect  mouse  cells.  One  of the  five  recipients  developed 
lymphoma at 5 mo. However, this strain, and AKR xenotropie virus, when inoculated 
into baby AKR mice as phenotypically mixed viruses possessing the envelope (and 
tropism) of an ecotropic virus, did not accelerate lymphoma in any of the recipients. 
Wild  mouse  amphotropic  viruses  (4070A,  1504A,  and  CasL1-A)  were  similarly 
ineffective in accelerating AKR lymphoma. 
Thus, of the viruses tested, only the MCF viruses from AKR and C58 mice were 
lymphomagenic in AKR. The results were the same whether baby or young adult 
mice were inoculated (Table II) and whether they were inoculated intrathymically or 
intraperitoneally (data not shown). 
To obtain an idea of the dose-response relationship of AKR MCF virus lymphom- 
agenesis, titrations of AKR MCF viruses were performed in suckling AKR mice (Fig. 
1). Inoculation of 103"5-s'6 flu of either AKR-247 or AKR-13  MCF  viruses induced 
lymphomas in all mice inoculated;  102.5-2.6 flu accelerated lymphoma in most of the 
mice; and the inoculation of 10  x'5-a'6 flu accelerated lymphoma in about one-half of 
the recipients. Thus, only small numbers of AKR MCF virus particles were required 
for lymphomagenesis, and the negative tests of the non-AKR isolates were not a result 
of the differences in virus titers. 
Lymphomagenicity Testing of MCF MuL V m  Various Strains of Mice.  The finding that 
only MCF viruses from AKR or C58 were able to accelerate AKR lymphomagenesis, 
whereas  MCF  viruses  from  several  other  strains  were  not  able  to,  suggested  the 
possibility that  the lymphomagenic ability of MCF  viruses may be strain  specific. 
That is, for any given mouse strain only the MCF viruses from that or similar strains TABLE  II 
Ability of Various Classes of MuL V to Accelerate Development of Lymphoma  in AKR/J Mice* 
Incidence of  Incidence of 
lymphoma by 6  Latency (Median  lymphoma by 6  Latency (Median 
Virus inoculated  mo of age when  and range)  mo of age when  and range) 
inoculated at  inoculated at  1 
2-4 d of age  mo of age 
MCF 
AKR-247  19/191: 
AKR- 13  8/8 
AKR-1659 
AKR-L3 
AKR-L4  7/7 
AKR-L5  6/6 
C58-L 1  b  9/9 
Fg-L3  0/11 
CB208  0/5 
NS ×  AK-L1 
Akv-I-C36  0/6 
Akv- 1-C93  0/8 
Akv-2-C35  0/5 
Akv-2-C25 
Akv-2-C26-2 
Akv-2-C34  0/9 
Akv-2-C78  0/5 
C58v-2-C45  1  / 13 
C58v- 1-C48  1/8 
C58v-1-C77  0/5 
Fgv-/-C647  0/6 
Ecotropic 
AKRL1  1/5 
AKR-Th-2a 
Akv- I-T 1  0/9 
Akv-2-T1  0/9 
Akv- l-L2 
Akv-/-L 1  0/6 
WNI802N  0/5 
C58-Lla 
F/St-Th- 1  0/6 
BBR- 1-N  0/8 
Xenotropic 
BALB-IU- 1 
Phenotypically  mixed 
population  (eco- 
tropic  +  xeno- 
tropic) 
BALB-IU-  1 (AKRL  0/3 
l) 
AKR  2B-X  (AKR 
2B-Eco) 
Amphntropic 
4070A 
1504A 
Cas.L 1-A 
wk 
15 (9-23) 
15 (9-24) 
15 (11-21) 
15 (10-24) 
14 (10-17) 
23 
23 
23 
wk 
25/25:j:  13 (8-18) 
10/10  14 (9-19) 
7/7  12 (8-16) 
3/3  14 (13-14) 
12/12  13 (10-16) 
0/7 
0/17 
0/5 
1/4 
0/11 
O/6 
O/5 
0/5 
0/5 
0/4 
0/7 
0/7 
18 
1/5  20 
o/5 
o/7 
0/14 
0/6 
0/6 
* Spontaneous lymphoma developed in all 35 uninoculated AKR controls, between 26 and 52 wk of age 
(median 34 wk). 
:~ Number of mice that developed lymphoma per number inoculated. 
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UNINOCULATED CONTROL 
I  i 
0  10  20  30 
WEEKS 
FIo.  1.  Incidence of lymphoma in AKR  mice after inoculation  at 2-5 d o£ age with dilutions o£ 
AKR-247 or AKR-13 MCF viruses. Numbers indicate the number o£ MCF flu injected per mouse; 
five to seven  mice were  inoculated  per virus dilution. 
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TABL~ III 
Lymphomagenicity of MCF MuL V in Various Strains of Mice Inoculated as Sucklings 
Murine  N-B  Incidence of lymphoma 
Virus inocu- 
strain of ori-  tro- 
lated 
gin  plsm  C3H/Bi*  NFS*  Sw.Akv-2",  4  Sw.Akv-I~  C57BR~  C58:~  DBA/2*  BALB/c* 
AKR-247  AKR  N  7115 (16)§  0133  717 (19) 
AKR-13  AKR  N  0/4  0/15  4110  (20) 
AKR-L4  AKR  N  0/12 
Akv-2-C34  Sw.Akv-2  N  015  0/7 
Akv-2-C78  Sw.Akv-2  N  019 
Akv-I-C36  Sw.Akv-I  N  0/5  3/8 (32) 
C58v-2-C45  Sw.C58v-2  N  0/4 
C58v-I-C48  Sw.C58v-I  N  015 
C58v-I-C77  Sw.C58v-I  N 
Fgv-  I-C647  Sw.Fgv-  /  N  016  015 
CB208  BALB/c  B 
7112 (ll)  0/4  0/7  0/5  0/6 
I/5 (24)  0/7  0/6 
0/11  0/5  0/4 
1/11 (36) 
4/li (40)  014  016 
0/6 
015 
O/4 
0/14 
* Data to 1.5 yr of age. 
:[: Data to I yr of age. (Mortality of uninoculated congenics from all causes is -15% at 1 yr of age.) 
§ Number of mice that developed lymphoma per number inoculated  (median  latent  period, in weeks). 
may be capable of inducing lymphoma. To further explore this hypothesis, homolo- 
gous  and  heterologous  MCF  MuLV  isolates  were  tested  for  lymphomagenicity  in 
various strains of mice. 
The prototype AKR MCF  virus  (AKR-247),  which was lymphomagenic in AKR 
mice,  was  inoculated  into  a  number  of other  inbred  strains  (Table  III).  It  was 
moderately lymphomagenic in C3H/Bi, Sw.Akv-1,  and Sw.Akv-2 mice, but it was not 
lymphomagenic  in C57BR,  C58,  DBA/2,  BALB/c,  and  NFS  mice.  AKR-13  MCF 
virus was also lymphomagenie, although only weakly,  in Akv-1  and Akv-2  congenic 
mice;  no lymphomas were induced  in the other strains tested,  including C3H/Bi.  A 
third  AKR  MCF  virus  (AKRL4)  was also nonlymphomagenic  in  NFS  mice.  Two 
MCF isolates from Sw.Akv-2 mice (Akv-2-C34  and Akv-2-C74)  and one from a Sw.Akv- 
1 mouse (Akv-l-C36)  were not lymphomagenie  in NFS,  C58,  or DBA/2.  The Akv-2 548  LYMPHOMAGENICITY OF MINK CELL FOCUS-INDUCING VIRUSES 
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MCF  VIRUSES INOCULATED 
F=G. 3.  Recovery of MCF viruses from  Sw.Akv-I and Sw.Akv-2 mice  inoculated  as sucklings. 
Thymus  (0) and spleen (O) cells from individual congenic mice inoculated 4-6 wk previously with 
various MCF viruses were scored  for replication  of MCF by infectious center assays. Uninoc., 
uninoculated. 
congenic MCF viruses were similarly not pathogenic in congenic mice, but Akv-l-C36 
MCF  virus  demonstrated  some  ability to  induce  hematopoietic  neoplasms  in  the 
congenics after a  relatively long latency. Three isolates from Sw.C58v-1 or Sw.C58v-2 
mice (C58v-2-45, C58v-l-C48, and C58v-l-C77 MCF viruses) were essentially negative 
for lymphoma induction in NFS or C58 mice. An MCF virus from a  Sw.Fgv-1 mouse 
was ineffective in inducing lymphoma in NFS and C3H/Bi  mice, and CB208  MCF 
of BALB/c origin was not pathogenic in BALB/c mice (Table III). 
Recovery of Virus  from MCF  MuL V-inoculated Mice.  Virus-recovery studies were carried 
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the thymus, or if the difference between leukemogenic and nonleukemogenic strains 
was  production of a  transforming  vs.  nontransforming infection.  Fig.  2  shows  the 
results of tests for recovery of MCF virus from thymus and spleen cells of AKR mice 
inoculated  3-6 wk  previously with  lymphomagenic and  nonlymphomagenic MCF 
viruses. Thymus cells from mice inoculated with  the lymphoma-accelerating MCF 
viruses  regularly  registered  as  MCF  virus-producing  infectious  centers,  with  an 
efficiency of 0.01-0.17%. In contrast, only one of the eight nonlymphomagenic MCF 
tested replicated in the AKR thymus, and in that case the number of infected cells 
was ~ 10-fold less than with the lymphomagenic strains. In general, the MCF viruses 
showed virtually no replication in the spleen; one strain (AKR-13) was exceptional in 
being detected in the majority of spleens. 
Similar patterns were seen in MCF-inoculated Sw.Akv-1 or Sw.Akv-2 mice (Fig. 3); 
higher MCF  virus titers were recovered from mice  inoculated with  AKR-247  and 
AKR-13  MCF  viruses  than  from  mice  inoculated with  Akv-l-C36  and  Akv-2-C34 
MCF  viruses, and  greater quantities  of virus were always  found in  the  thymus  as 
compared with the spleen. 
Discussion 
From the data reported here it is clear that MCF viruses fall into two classes with 
respect to ability to induce lymphomas. The lymphomagenic strains were all derived 
from thymic tissue, either normal or malignant,  and  in  turn  these strains were all 
from AKR or C58 mice. The MCF isolates from NIH Swiss congenic mice carrying 
ecotropic virus-inducing loci, including loci derived from AKR and C58, were without 
exception unable to accelerate AKR lymphoma;  furthermore, they did not  induce 
lymphoma in any other mouse strain tested, including some of the congenic strains of 
origin.  With  one exception, the nonthymomagenic strains were derived from non- 
thymic hematopoietic neoplasms and were unable to establish significant infection of 
thymic cells.  The  exception is  Akv-l-C36  MCF  virus,  which  was  isolated  from  a 
thoracic lymphoma of an Akv-1  congenic mouse;  it was not clear if the lymphoma 
arose in thymus or mediastinal lymph nodes. This MCF strain, although negative in 
the AKR acceleration test, replicated to a  moderate degree in the thymus  (Fig. 2); 
and in preliminary studies it was able to induce AKR thymomas when injected as a 
phenotypicaUy mixed population with  AKR  ecotropic virus  (M.  W.  Cloyd, J.  w. 
Hartley,  and  W.  P.  Rowe.  Unpublished  data.).  It  also  appeared  to  be  weakly 
oncogenie in Akv-I and Akv-2 congenic mice after long latency (Table III). 
Thus several points seem noteworthy from this work. One is that recombination in 
the envelope (env) gene does not necessarily render MuLV lymphomagenic, because 
both thymotropic and nonthymotropic MCF strains have been shown to be env gene 
recombinants  (11,  12).  Secondly, the recombinants that are thymomagenic are also 
thymotropic, having the  ability  to efficiently replicate in  thymic cells.  Lastly, the 
mouse strain and/or tissue of origin seem to be important factors in derivation of the 
thymotropic, thymomagenic, recombinant viruses. 
Thymotropism may be a property reflective of the xenotropic parents of the various 
recombinant MCF viruses, which in turn could relate to strain of origin or to tissue- 
specific expression of one or another type of xenotropic virus.  It  also could reflect 
different  selective  pressures  in  the  strain  of origin;  that  is,  recombinant  viruses 
recovered from thymic tissue might be a  selected population adapted to be able to 
establish  exogenous  infection  in  thymic  cells.  In  contrast,  the  MCF  strains  from 550  LYMPHOMAGENICITY  OF  MINK CELL FOCUS-INDUCING VIRUSES 
nonthymic tissue would have been selected for ability to grow in other cell types. The 
critical importance of thymotropism for ability of an MuLV strain to induce thymoma 
has been stressed by Decl~ve et al. (20)  for radiation leukemia virus, and is fully borne 
out for MCF viruses by our findings.  However, recent evidence  2 indicates that some 
dual-tropic viruses are thymotropic in AKR, as measured by antigen amplification, 
but do not appear to be lymphomagenic. 
The viral genetic factors that determine whether an MCF strain is thymotropic or 
not (and very likely thymomagenic or not) will be of much interest to determine. The 
MCF viruses have been shown to be heterogeneous by tryptic digest analysis of the 
major virion glycoprotein (11), and by T1 RNase oligonucleotide fingerprints of their 
genomes (12).  More recent  extensive analyses  3 have shown that  the genomes of the 
two classes of MCF  viruses  (lymphomagenic and  nonlymphomagenic),  indeed,  fall 
into two distinctly different patterns. 
With respect to the MCF isolates from AKR mice, our studies fully bear out  the 
idea  that  they  are  the  proximal cause of spontaneous  AKR  thymomas. They first 
appear in  the AKR thymus  in  close temporal relationship  to the preleukemic and 
leukemic  cellular  changes;  they  are  regularly  present  in  AKR  thymomas;  and  as 
shown here, they have the capacity to markedly accelerate the appearance of AKR 
thymomas and to induce thymomas in the low-leukemic strain C3H/Bi. In contrast, 
the AKR ecotropic virus was not  lymphomagenic, nor was a  phenotypically mixed 
population of AKR ecotropic and xenotropic viruses. 
Though  highly active in the AKR acceleration test, the AKR MCF  viruses were 
not  highly  leukemogenic  in  other  systems, even  though  the  recipient  strains  were 
selected  for  carrying  Fv-I  alleles  that  were  permissive  for  the  MCF  viruses  being 
tested.  Also,  many of the strains  tested  carry the  H-2  k and  //-2  a  alleles,  which  are 
associated with sensitivity to viral leukemogenesis (21). Of particular interest was that 
the  presence  of  high-level  expression  of endogenous  ecotropic  virus  appeared  to 
facilitate MCF  leukemogenesis, as  indicated  by the positive results obtained  in  the 
NIH mice carrying the Akv virus-inducing loci as compared with the negative results 
in  the  NFS  or  NIH  Swiss  mice.  The  presence  of ecotropic  virus  may  facilitate 
thymomagenesis by allowing more rapid spread of MCF virus in the thymus by virtue 
of phenotypic mixing; it may facilitate by interfering with immune response against 
the  MCF  virus,  such  as  by  inducing  tolerance  or  immunosuppression;  or  it  may 
provide conditions  for further rounds  of recombination  to produce  a  transforming 
variant.  However, expression  of endogenous  ecotropic  virus was  not  obligatory  for 
leukemogenicity, as shown by the positive results obtained in C3H/Bi mice, a strain 
with  very low level expression of endogenous ecotropic virus  (M.  W.  Cloyd, J.  W. 
Hartley,  and  W.  P.  Rowe.  Unpublished  data.).  Genetic  studies  are  in  progress  to 
better define the various host genes involved in MCF lymphomagenesis. 
Summary 
Recombinant mink cell focus-inducing (MCF)  murine leukemic viruses, as well as 
ecotropic  and  xenotropic  viruses,  were  tested  for  ability  to  accelerate  or  cause 
z O'Donnell, P. V., E. Stockert, Y. Obata, A. B. DeLeo, and L. J. Old. Murine leukemia virus-related 
cell surface antigens as serologic markers of AKR ecotropic, xenotropic, and dual-tropic viruses. Cold Spring 
Harbor Syrup. Quant. Biol. In press. 
a Li Lung, M., C. Hering,  J. W. Hartley, W. P. Rowe, and N. Hopkins. Analysis  of the genomes  of MCF 
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development of lymphoma in AKR and other strains of mice. Of the three classes of 
virus isolated from AKR, only the MCF viruses were able to accelerate development 
of AKR  lymphoma.  This  fully  supports  the  idea  that  the  MCF  viruses  are  the 
proximal cause of spontaneous AKR lymphoma. MCF lymphomagenicity was strain 
specific, however,  in  that  AKR MCF  viruses  did  not  induce  lymphomas in  many 
murine  strains;  they  were  moderately  lymphomagenic  in  C3H/Bi  mice  and  in 
National Institutes of Health Swiss  partially congenic for Akv-1 or Akv-2.  In contrast, 
MCF viruses from nonthymic hematopoietic neoplasms of C3H/Fg, BALB/c, or mice 
partially  congenic for ecotropic virus loci  (Akv-l,  Akv-2,  Fgv-l,  C58v-1,  and  C58v-2) 
were not able to accelerate or cause lymphoma in AKR or any other mouse strain 
tested,  including some of the  strains  of origin.  MCF  lymphomagenicity correlated 
with thymic origin of the virus and with ability to replicate in the thymus. 
We thank S.  Hourihan and M. Whiteman for expert  technical  assistance, and S. Grove for 
assistance in preparing this manuscript. 
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